en <span style=font-size:12pt><span style=font-family:Times New Roman,serif><b><span lang=EN-ID style=font-size:10.0pt><span style=font-family:Cambria,serif><span style=color:#4f81bd>Aims:</span></span></span></b> <span style=font-size:10.0pt><span style=font-family:Cambria,serif>Tuberculosis is still a significant global health challenge, particularly in developing countries. </span></span><span lang=id style=font-size:10.0pt><span style=font-family:Cambria,serif>This study aimed to evaluate the impact of the TB SEHAT application on medication adherence among pulmonary </span></span><span style=font-size:10.0pt><span style=font-family:Cambria,serif>tuberculosis </span></span><span lang=id style=font-size:10.0pt><span style=font-family:Cambria,serif>patients in Jambi City.</span></span> <a name=_Hlk150275412><span style=font-size:10.0pt><span style=font-family:Cambria,serif></span></span></a></span></span><br> <span style=font-size:12pt><span style=font-family:Times New Roman,serif><b><span lang=EN-ID style=font-size:10.0pt><span style=font-family:Cambria,serif><span style=color:#4f81bd>Materials & Methods:</span></span></span></b><span lang=EN-ID style=font-size:10.0pt><span style=font-family:Cambria,serif> This quasi-experimental study employed a one-group pre-test-post-test design with a control group, comprising two groups; an intervention group that received TB SEHAT app-based education and a medication reminder program, and a control group that received standard care from medication supervisors. Each group included 37 participants, selected through simple random sampling. Data collection was done from May 13 to August 30, 2024, within the service area of the Putri Ayu Health Center. Data analysis was performed by </span></span><span lang=id style=font-size:10.0pt><span style=font-family:Cambria,serif>SPSS 23</span></span><span lang=EN-ID style=font-size:10.0pt><span style=font-family:Cambria,serif>.</span></span> <span style=font-size:10.0pt><span style=font-family:Cambria,serif></span></span></span></span><br> <span style=font-size:12pt><span style=font-family:Times New Roman,serif><b><span lang=EN-ID style=font-size:10.0pt><span style=font-family:Cambria,serif><span style=color:#4f81bd>Findings:</span></span></span></b> <span style=font-size:10.0pt><span style=font-family:Cambria,serif>Following the use of the TB SEHAT application, the mean adherence to anti-tuberculosis drugs was 127.30±5.22 on the TB Medication Adherence Scale. In contrast, the mean adherence in the group receiving standard treatment supervision was 121.41±6.43. An analysis of covariance indicated a significant difference in adherence between the TB SEHAT application and standard treatment groups (p=0.001). </span></span></span></span><br> <span style=font-size:12pt><span style=font-family:Times New Roman,serif><b><span lang=EN-ID style=font-size:10.0pt><span style=font-family:Cambria,serif><span style=color:#4f81bd>Conclusion:</span></span></span></b><span style=font-size:10.0pt><span style=font-family:Cambria,serif> The TB SEHAT application effectively improves adherence to </span></span><span lang=id style=font-size:10.0pt><span style=font-family:Cambria,serif><span style=letter-spacing:-.05pt>anti-tuberculosis </span></span></span><span style=font-size:10.0pt><span style=font-family:Cambria,serif>drugs in patients with pulmonary tuberculosis.</span></span></span></span> Tuberculosis, Pulmonary,Nursing,Mobile Applications,Medication Adherence, 1 6 http://daneshafarand.org/browse.php?a_code=A-10-85623-1&slc_lang=en&sid=4